Articles

Antiplatelet properties of Pim kinase inhibition are mediated through disruption of thromboxane A2 receptor signaling

University of Reading and Dept. of Life Sciences, Manchester Metropolitan University Manchester, UK;
Institute for Cardiovascular, Metabolic Research, University of Reading, Reading, UK;
Institute for Cardiovascular and Metabolic Research, University of Reading, Reading, UK;
Institute for Cardiovascular and Metabolic Research, University of Reading, Reading, UK;
Blood Research Institute and Medical College of Wisconsin, Versiti, Milwaukee, WI, USA;
Blood Research Institute, Versiti, Milwaukee, WI, USA;
Institute for Cardiovascular and Metabolic Research, University of Reading, Reading, UK;
Institute for Cardiovascular and Metabolic Research, University of Reading, Reading, UK;
Blood Research Institute and Medical College of Wisconsin, Versiti, Milwaukee, WI, USA;
School of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, UK;
Department of Life Sciences, Manchester Metropolitan University, Manchester, UK;
Department of Life Sciences, Manchester Metropolitan University, Manchester, UK;
School of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, UK;
Blood Research Institute, Versiti and Medical College of Wisconsin, Milwaukee, WI, USA
Blood Research Institute, Versiti and Medical College of Wisconsin, Milwaukee, WI, USA
Institute for Cardiovascular and Metabolic Research, University of Reading, Reading, UK;
Vol. 106 No. 7 (2021): July, 2021 https://doi.org/10.3324/haematol.2019.223529